All Articles

The recent $5.2M sale of a Sleep Inn & Suites in Valdosta, GA, highlights ongoing investor confidence in well-positioned midscale hotels and a thriving Southeast tourism sector. Strategic renovations played a key role in the deal.

New funding fuels RapidSOS’s expansion of its AI-powered platform connecting millions of devices to 22,000+ public safety agencies, accelerating a shift towards faster, data-driven emergency response.

Positive interim data from Protara Therapeutics’ Phase 2 trial of TARA-002 offers hope for pediatric patients with lymphatic malformations, a rare disease with limited effective therapies. The company’s cell-based approach builds on an established Japanese treatment.

Canada’s Choice Properties REIT authorizes repurchase of up to 10% of its public float, reflecting a bullish outlook amidst evolving real estate market conditions and a commitment to shareholder value.

A landmark partnership between Oklo and Siemens Energy signals growing momentum for small modular reactors. This deal, along with Oklo’s progress in licensing and funding, positions the company as a key player in the evolving nuclear landscape.

Facing a competitive landscape and evolving business model, Vivos Therapeutics is doubling down on direct patient access through strategic acquisitions and expanding its sleep center network. Can this strategy fuel profitability?

American Lending Center appoints Gary Merson as EVP, bolstering compliance and strategic growth within the EB-5 immigrant investor program. The move comes as the industry navigates new regulations and increased scrutiny.

DeFi Development Corp. is making waves as the first U.S. public company to center its treasury around Solana. But is this bold move a harbinger of future finance, or a risky gamble for investors?

A recent sale of shares by Endeavour Mining’s CFO has sparked investor questions, even as the gold producer reports robust Q3 results and positive future outlook. What’s behind the transaction?

Aptorum Group's planned acquisition of DiamiR Biosciences signals a growing confidence in liquid biopsies for early Alzheimer's detection. The move targets a multi-billion dollar market and offers hope for more accessible diagnostics.

Global veterinary hospital market poised for robust growth, hitting $110.72B by 2032. Tech advancements, increasing pet ownership, and rising insurance adoption are key drivers. A deep dive into the evolving landscape.

NanoVibronix’s strategic shift to ENvue Medical represents a bold bet on navigation technology. The company is divesting acoustic therapies to focus on improving enteral tube placement and expanding into new applications.

Hyperfine receives $3.7M from the Gates Foundation to expand access to brain imaging for infants in resource-constrained settings, leveraging AI and portable MRI technology.

NANO Nuclear Energy’s innovative pump technology is poised to unlock the potential of small modular reactors, promising durable, low-maintenance power for remote locations and beyond. But can the company scale up fast enough?

A Silicon Valley packaging company is investing $500,000 in reforestation efforts following devastating wildfires. But is corporate-funded restoration a sustainable solution or simply greenwashing?

Clinical-stage biotech BioVie is advancing therapies targeting neuroinflammation and liver disease, with promising data from Alzheimer’s and Parkinson’s trials. The company is hosting an investor webinar to discuss progress.

A collaboration between Care Access and the Association of Black Cardiologists aims to expand access to vital heart health screenings and education, addressing a critical disparity in preventative care.

Harmony Biosciences initiates a Phase 1 trial for BP1.15205, an orexin 2 receptor agonist, aiming to address unmet needs in narcolepsy, idiopathic hypersomnia, and other central hypersomnolence disorders. Could this expand the company's sleep franchise?

GoLocker and Toys for Hospitalized Children team up to leverage secure package lockers as donation points, streamlining toy collection and bringing joy to young patients this holiday season.

A new TV ad campaign from Orion Metal Exchange aims to disrupt the often-opaque world of precious metals investing. The company emphasizes transparency, lower fees, and a customer-first approach, but does it deliver on its promises?